Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Five year treatment with IGF-I of a patient with Laron syndrome in Slovenia (a follow-up report).

Journal of pediatric endocrinology & metabolism : JPEM - 1 Jan 2000

Krzisnik C, Battelino T

Abstract excerpt

This is a follow-up report of a 14 1/2 year-old boy with Laron syndrome, who received twice daily therapy with IGF-I 120 micrograms/kg for 5 years that resulted in a linear growth of 40 cm. Concomitantly he became very obese which is attributed to IGF-I action via the insulin receptors.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Height
Share to Child
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Growth Disorders

Share to Insulin-Like Growth Factor I

Share to Mutation

Share to Recombinant Proteins

Share to Syndrome

Source

Identifiers

PMID: 9364374
DOI: 10.1515/jpem.1997.10.4.443

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Five year treatment with IGF-I of a patient with Laron syndrome in Slovenia (a follow-up report).PMID 9364374Read ↗

Long-term IGF-I treatment of children with Laron syndrome increases adipositySemantic proximity Read ↗

Ten-year improvement of insulin resistance and growth with recombinant human insulin-like growth factor 1 in a patient with insulin receptor mutations resulting in leprechaunism.Semantic proximity Read ↗

The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome.Semantic proximity Read ↗

Disabilities and Handicaps of Patients with Laron SyndromeSemantic proximity Read ↗

Insulin-like growth factor 1 (IGF-1): a growth hormoneSemantic proximity Read ↗

Growth hormone insensitivity syndrome (Laron syndrome): main characteristics and effects of IGF1 treatment.Semantic proximity Read ↗

Laron syndrome - A historical perspective.Semantic proximity Read ↗

IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome.Semantic proximity Read ↗

Review of Turkish patients with growth hormone insensitivity (Laron type).Semantic proximity Read ↗

[Leprechaunism caused by mutations in the insulin receptor gene].Semantic proximity Read ↗

Clinical, biochemical and molecular investigations of three Taiwanese children with Laron syndrome.Semantic proximity Read ↗

Growth curves for Laron syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.